|
Journal of Lipid Research, Vol. 41, 376-383, March 2000
Copyright © 2000 by Lipid Research, Inc.
Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages
Joseph A. Cornicellia,
Dustie Butteigerb,
Debra L. Raterib,
Kathryn Welcha, and
Alan Daughertyb
a Department of Vascular and Cardiac Diseases, Parke Davis, 2800 Plymouth Road, Ann Arbor, MI 48106
b Gill Heart Institute, Atherosclerosis Research Group, Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY 40536
Correspondence to:
Joseph A. Cornicelli
Correspondence to:
Alan Daugherty
Activated subpopulations of lymphocytes and mast cells have been detected in atherosclerotic lesions. Interleukin-4 (IL-4) is a prominent cytokine released during activation of both cell types and its transcripts have been detected in both human and mouse atherosclerotic lesions. To define whether this local release of IL-4 influences macrophage lipid metabolism, we examined the effects of this cytokine on intracellular cholesterol esterification during incubation with modified low density lipoprotein (LDL). IL-4 greatly augmented cholesterol esterification induced by acetylated LDL (AcLDL) in both mouse peritoneal macrophages and the murine macrophage cell line, J774. This augmentation was maximal at a concentration of 1 ng/ml after incubation for 48 h. This was not a generalized effect on lipoprotein metabolism as IL-4 had no effect on cholesterol esterification in the presence of either LDL or ß-VLDL. Determination of binding isotherms demonstrated that IL-4 increased the number of cell surface binding sites for AcLDL. The IL-4-augmented AcLDL-induced cholesterol esterification was attenuated by the scavenger receptor class A (SR-A) antagonist, fucoidan, and the anti-mouse SR-A monoclonal antibody, 2F8.
These data, combined with the known receptor specificity of AcLDL interactions, imply a role of SR-A in the IL-4 induced responses. Two cytokines that have been demonstrated previously to down-regulate SR-A, TNF- and TGF-ß, antagonized the IL-4-induced augmentation of cholesterol esterification. Therefore, local release of IL-4 within atherosclerotic lesions could have a profound effect on macrophage lipid metabolism and the subsequent atherogenic process.Cornicelli, J. A., D. Butteiger, D. L. Rateri, K. Welch, and A. Daugherty. Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages. J. Lipid Res. 2000. 41: 376;383.
Supplementary key words:
scavenger receptor, CD36, LDL, ß-VLDL, cytokines

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Rogers, S. Burchat, J. Gage, M. Hasu, M. Thabet, L. Wilcox, T. A. Ramsamy, and S. C. Whitman
Deficiency of invariant V{alpha}14 natural killer T cells decreases atherosclerosis in LDL receptor null mice
Cardiovasc Res,
April 1, 2008;
78(1):
167 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. King, L. A. Cassis, and A. Daugherty
Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice
Am. J. Pathol.,
December 1, 2007;
171(6):
2040 - 2047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. O. Martinez, S. Gordon, M. Locati, and A. Mantovani
Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression
J. Immunol.,
November 15, 2006;
177(10):
7303 - 7311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev,
April 1, 2006;
86(2):
515 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King
Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis
J. Lipid Res.,
September 1, 2005;
46(9):
1812 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev,
October 1, 2003;
83(4):
1069 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev.,
March 1, 2003;
55(1):
133 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Post, C. Gass, S. Rice, D. Nikolic, H. Crump, and G. R. Post
Class A scavenger receptors mediate cell adhesion via activation of Gi/o and formation of focal adhesion complexes
J. Lipid Res.,
November 1, 2002;
43(11):
1829 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. King, S. J. Szilvassy, and A. Daugherty
Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor-/- Mice
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2002;
22(3):
456 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Whitman, P. Ravisankar, H. Elam, and A. Daugherty
Exogenous Interferon-{{gamma}} Enhances Atherosclerosis in Apolipoprotein E-/- Mice
Am. J. Pathol.,
December 1, 2000;
157(6):
1819 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Daugherty, S. C. Whitman, A. E. Block, and D. L. Rateri
Polymorphism of class A scavenger receptors in C57BL/6 mice
J. Lipid Res.,
October 1, 2000;
41(10):
1568 - 1577.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. C. Whitman, A. Daugherty, and S. R. Post
Regulation of acetylated low density lipoprotein uptake in macrophages by pertussis toxin-sensitive G proteins
J. Lipid Res.,
May 1, 2000;
41(5):
807 - 813.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|